Trastuzumab after adjuvant chemotherapy in older patients

Lancet. 2007 Mar 24;369(9566):991; author reply 991-2. doi: 10.1016/S0140-6736(07)60492-9.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Age Factors
  • Aged
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Middle Aged
  • Randomized Controlled Trials as Topic
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Trastuzumab